Eli Lilly's diabetes pill takes market share from J&J, Astra

(Reuters) - Eli Lilly and Co's new Jardiance diabetes treatment has begun stealing market share from rival drugs in its class, the company said on Tuesday, bolstered by clinical trial data showing it slashed deaths by 32 percent in patients with Type 2 diabetes.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro